35例直肠类癌患者内镜下治疗的回顾性分析  

Retrospective Analysis of Endoscopic Treatment in 35 Patients with Rectal Carcinoid

作　　者：徐呈 吴高珏[1] 王小云[1] 唐学军[1] 陆健[1] 刘智娟 XU Cheng;WU Gao-jue;WANG Xiao-yun(Department of Gastroenterology,The Affiliated Wuxi Second People's Hospital,Wuxi,Jiangsu,214000,China)

机构地区：[1]无锡市第二人民医院消化内科

出　　处：《黑龙江医学》2019年第10期1158-1160,共3页Heilongjiang Medical Journal

摘　　要：目的 探讨直肠类癌患者行内镜下黏膜剥离术(endoscopic submucosal dissection,ESD)的疗效及安全性.方法 选取2015年1月-2018年1月期间的35例直肠类癌(直径<20 mm)患者行ESD治疗.镜下标识预切除范围,黏膜下注射抬高病灶,黏膜切开及创面钛夹处理.结果 35例直肠类癌直径为1.5~2.0 cm,均一次性切除,病灶基底及切缘均未累及.随访3~5年均无复发.结论 对于直径<2 cm、无远处转移、未侵及固有肌层的直肠类癌患者,行ESD术疗效确切、简单、安全可靠,适宜开展.Objective To investigate the efficacy and safety of endoscopic submucosal dissection(ESD)in patients with rectal carcinoid.Methods 35 patients with rectal carcinoid(<2 0 mm in diameter)from January,2015 to January,2015 were treated with ESD.Microscopically,the pre-resection range,submucosal injection elevation lesion,mucosal incision and wound titanium clip were identified.Results 35 cases of rectal carcinoid tumors were 1.5~2.0 cm in diameter,all of which were resected at one time.The lesion base and cutting margin were not involved.There was no recurrence after 3~5 years of follow-up.Conclusion For patients with rectal carcinoids with diameter<2 cm no distant metastasis,and no invasion of the muscularis propria,ESD is effective,simple,safe and reliable.

关 键 词：内镜黏膜下剥离术 直肠类癌 病理 

分 类 号：R541[医药卫生—心血管疾病]